Here’s how the ‘pause’ on J&J’s COVID-19 shot may affect the company’s earnings
April 16, 2021 at 12:17 PM EDT
To what degree will Johnson & Johnson’s COVID-19 vaccine manufacturing issues and the federal 'pause' over safety concerns weigh on investors' mind when the company reports earnings next week?
